´ëÇÑ»êºÎÀΰúÇÐȸ(ÀÌ»çÀå °­¼ø¹ü)°¡ 25∼27ÀÏ ±×·£µåÈúÆ°È£ÅÚ ÄÁº¥¼Ç¼¾ÅÍ¿¡¼­ ÁøÇàÁßÀÎ Á¦13Â÷ ¼­¿ï½ÉÆ÷Áö¾ö ¹× Á¦94Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ ÃÖ¿ì¼ö³í¹®»ó ¹× Çмú»ó ¼ö»óÀÚ¸¦ ¼±Á¤Çß´Ù. ¼ö»óÀÚµéÀÇ °­¿¬¹ßÇ¥´Â 26ÀÏ ¿ÀÀü 9½Ã 20ºÐºÎÅÍ 9½Ã 40ºÐ±îÁö ÁøÇàµÈ´Ù.   

¼ö»óÀÚ ¸í´ÜÀº ´ÙÀ½°ú °°´Ù. 

¡ßACCUVIX »ó
ºÐ¾ß : ¸ðüžÆÀÇÇÐ
¼º¸í : ¹ÚÁ߽Š(¼­¿ïÀÇ´ë)
Á¦¸ñ : Measurement of Placental Alpha-Microglobulin-1 in Cervicovaginal Discharge to Diagnose Rupture of Membranes
°ÔÀçÁö : Obstetrics & Gynecology

¡ßASTRA ZENECA »ó
ºÐ¾ß : »ý½Ä³»ºÐºñÇÐ
¼º¸í : ±è¼ºÈÆ (¿ï»êÀÇ´ë)
Á¦¸ñ : Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes
°ÔÀçÁö : Human Reproduction

¡ßÇѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü »ó
ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
¼º¸í : ±èº´±â (¼º±Õ°üÀÇ´ë)
Á¦¸ñ : Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results
°ÔÀçÁö : International Journal of Radiation Oncology * Biology * Physics

¡ßBayer Schering Pharma, Gynecare »ó
ºÐ¾ß : ÀϹݺÎÀΰúÇÐ
¼º¸í : À¯ÀºÈñ (°æÈñÀÇ´ë)
Á¦¸ñ : Predictors of leiomyoma recurrence after laparoscopic myomectomy
°ÔÀçÁö : Journal of minimally invasive gynecology

 <Çмú»ó ¼ö»óÀÚ>
ºÐ¾ß : ¸ðüžÆÀÇÇÐ
¼º¸í : ¼Û½ÂÀº (¼º±Õ°üÀÇ´ë)
Á¦¸ñ : ÀӽŠÁ¦1 »ïºÐ±â ºÒÀÏÄ¡ ½ÖÅÂÀÓ½ÅÀÇ ÀÓ»óÀû °á°ú
°ÔÀç³âµµ : ´ëÇÑ»êºÎÀΰúÇÐȸÁö Vol. 50 No. 12 2007 

ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
¼º¸í : ÁÖ´ÙÇý (¿ï»êÀÇ´ë)
Á¦¸ñ : Àç¹ß¼º ¶Ç´Â Áö¼Ó¼º »óÇǼº ³­¼Ò¾Ï¿¡¼­ÀÇ Docetaxel ¿ä¹ýÀÇ È¿¿ë¼º ¹× µ¶¼º
°ÔÀç³âµµ : ´ëÇÑ»êºÎÀΰúÇÐȸÁö Vol. 50 No. 11 Nov 2007